SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001103021-21-000042
Filing Date
2021-05-06
Accepted
2021-05-06 17:01:34
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bdsi-20210331.htm   iXBRL 10-Q 836397
2 EX-31.1 bdsi-20210331x10qex311.htm EX-31.1 8384
3 EX-31.2 bdsi-20210331x10qex312.htm EX-31.2 8437
4 EX-32.1 bdsi-20210331x10qex321.htm EX-32.1 4617
5 EX-32.2 bdsi-20210331x10qex322.htm EX-32.2 4714
  Complete submission text file 0001103021-21-000042.txt   4340757

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsi-20210331.xsd EX-101.SCH 26594
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdsi-20210331_cal.xml EX-101.CAL 61514
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdsi-20210331_def.xml EX-101.DEF 158364
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsi-20210331_lab.xml EX-101.LAB 393012
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsi-20210331_pre.xml EX-101.PRE 256258
11 EXTRACTED XBRL INSTANCE DOCUMENT bdsi-20210331_htm.xml XML 692411
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 21898773
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences